# OnCo record nct07213804 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07213804/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07213804", "NCT07213804" ;
  schema:name "A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer"@en ;
  schema:alternateName "FRAmework-01"@en ;
  schema:description "A phase 3 trial testing Sofetabart Mipitecan in ovarian cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07213804/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07213804> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2025-10-22" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:drugs <https://onco.cc/drugs/sofetabart-mipitecan/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> .